alexa An open-label study of the efficacy and tolerability of microencapsulated hydroquinone 4\% and retinol 0.15\% with antioxidants for the treatment of hyperpigmentation.
Dermatology

Dermatology

Journal of Pigmentary Disorders

Author(s): CookBolden FE, Hamilton SF

Abstract Share this page

Abstract Hyperpigmentation describes areas of the skin with increased melanin content, when the pigmentation is darker than the healthy surrounding skin. Disorders of hyperpigmentation, such as melasma, postinflammatory hyperpigmentation (PIH), and solar lentigines, are common and pose a treatment challenge for all patients, particularly those with darker skin types whose melanocytes are more reactive to various stimuli. Although distressing when affecting the face and areas of the body that are difficult to conceal, disorders of hyperpigmentation can affect individuals from head to toe. An innovative product containing microencapsulated hydroquinone 4\% and retinol 0.15\% with antioxidants has improved hyperpigmentation disorders of the face based on disease severity, pigmentation intensity, lesion area, and colorimetric measurements. The objective of the current open-label study was to evaluate the efficacy and tolerability of microencapsulated hydroquinone 4\% and retinol 0.15\% with antioxidants in individuals with Fitzpatrick skin types II through VI with hyperpigmentation of the face and/or body and to determine if this hydroquinone preparation was as effective on the body as it was on the face. Participants were treated twice daily for 12 weeks. Study evaluations were conducted at baseline and weeks 4, 8, and 12. Results from the efficacy assessments demonstrated that reductions in lesion size, darkness, and disease severity were significant as early as 4 weeks after treatment initiation and remained significantly reduced throughout the study (all P < .032). Furthermore, 63\% of participants (12/19) had either marked improvement (defined as 75\% overall improvement) or complete clearing (> or = 95\% overall improvement) of their hyperpigmented lesions at the end of the 12-week treatment period. Reflectance spectrophotometer readings also were performed at each study visit and demonstrated a significant reduction in melanin content as early as week 4 (target A, P < or = .001; target B, P = .002).
This article was published in Cutis and referenced in Journal of Pigmentary Disorders

Relevant Expert PPTs

Relevant Speaker PPTs

  • Heidi Schalchli
    Natural products of Anthracophyllum discolor: Ligninolytic enzymes and antifungal volatile compounds
    PPT Version | PDF Version
  • K.E. Shady
    Change of the physical properties of colored high density polyethethylene by effect of environment
    PPT Version | PDF Version
  • Flavia Secco Tavares de Souza
    A Comparative Study Among Elective Conventional Surgery, Urgency/Emergency Conventional Approaching and Elective Videolaparoscopic Surgery on the Treatment of Hospitalized Patients at First Surgeric Clinic of Federal Hospital of Bonsucesso with a Diagnostic of Colorectal adenocarcinoma, between January 2010 and December 2012
    PPT Version | PDF Version
  • V Keshava Rao
    Genotypic variability in color, pungency and antioxidant activity among Chilli genotypes
    PPT Version | PDF Version
  • Diganta Kalita
    Polyphenol content and antioxidant activity of potato tubers with colored flesh: Their potential role in acrylamide formation in french fries
    PPT Version | PDF Version

Recommended Conferences

Relevant Topics

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords